Pharmacokinetics of oral dehydroepiandrosterone (DHEA) in the ovariectomised cynomolgus monkey

Journal of Steroid Biochemistry and Molecular Biology

Volumn 81, Issue 2, 2002, Pages 159-164

  Leblanc, Mathias ^a   Labrie, Claude ^a   Bélanger, Alain ^a   Candas, Bernard ^a   Labrie, Fernand ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Androgens; DHEA; Estrogens; Intracrinology; Monkey; Oral; Pharmacokinetics; Steroidogenesis

Indexed keywords

ANDROGEN; ANDROSTENEDIOL; ANDROSTENEDIONE; ANDROSTERONE DERIVATIVE; ESTRADIOL; ESTROGEN; ESTRONE; GLUCURONIDE; PLACEBO; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONE BLOOD LEVEL; HORMONE METABOLISM; MONKEY; NONHUMAN; OVARIECTOMY;

ADMINISTRATION, ORAL; ANDROSTENEDIONE; ANIMALS; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; MACACA FASCICULARIS; OVARIECTOMY; PLACEBOS; TESTOSTERONE;

MACACA FASCICULARIS; PRIMATES;

EID: 0036345384     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(02)00059-6     Document Type: Article

References (34)

1. Role of DHEA transformation into androgens and estrogens in peripheral intracrine tissues
2. The actions of exogenous dehydroepiandrosterone in experimental animals and humans
3. Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate
4. DHEA and its transformation into androgens and estrogens in peripheral target tissues: Intracrinology
5. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood
6. Age and sex-related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects
7. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging
8. Changes in serum concentrations of conjugated and unconjugated steroids in 40-80-year-old men
9. Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat
10. Almost exclusive androgenic action of dehydroepiandrosterone in the rat mammary gland
11. Effect of dehydroepiandrosterone and the antiestrogen EM-800 on the growth of human ZR-75-1 breast cancer xenografts
12. Effect of 12-month DHEA replacement therapy on bone, vaginum, and endometrium in post-menopausal women
13. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge study to a sociobiomedical issue
14. Metabolic effects of 12-month percutaneous DHEA replacement therapy in post-menopausal women
15. Neurosteroids: A new function in the brain
16. Dehydroepiandrosterone: Biosynthesis and metabolism in the brain
17. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age
18. Serum dehydroepiandrosterone and DHEA-sulfate in Alzheimer's disease and in cerebrovascular dementia
19. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage
20. Dehydroepiandrosterone (DHEA) treatment of depression
21. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: Intracrinology
22. Sex differences in the pharmacokinetics of dehydroepiandrosterone (DHEA) after single- and multiple-dose administration in healthy older adults
23. Oral dehydroepiandrosterone for adrenal androgen replacement: Pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression
24. Dehydroepiandrosterone replacement in women with adrenal insufficiency
25. Dehydroepiandrosterone replacement administration: Pharmacokinetic and pharmacodynamic studies in healthy elderly subjects
26. Acute oral administration of dehydroepiandrosterone in male subjects: Effects of age and bioconversion in other steroids
27. Post-menopausal steroid replacement with micronized dehydroepiandrosterone: Preliminary oral bioavailability and dose proportionality studies
28. Intracrinology: Role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease
29. The production and aromatization of dehydroepiandrosterone in post-menopausal women
30. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in post-menopausal women
31. Biotransformation of oral dehydroepiandrosterone in elderly men: Significant increase in circulating estrogens
32. Replacement of DHEA in aging men and women. Potential remedial effects
33. Delivery of dehydroepiandrosterone to post-menopausal women: Effects of micronization and nonoral administration
34. Metabolism of dehydroepiandrosterone